Medical Membrane Market - Size, Share,
Outlook and Opportunity Analysis 2018-
2026
A medical membrane is a synthetically created membrane, which is usually use for separation
purposes in healthcare industry or in laboratory. Medical membranes have been successfully
used for large and small scale industrial processes since the middle of twentieth century.
Increasing use of medical membrane in hemodialysis and pharmaceutical filtration are the major
factors propelling the global medical membrane market growth. These membranes are widely
used in various medical applications such as venting & gas filtration, pre-filtration, sterile
filtration, infusion therapy, and sample preparation. The medical membrane provides superior
flow and fast filtration rate in aqueous solution to filter out bacteria, fine particles, and fungi.
Medical membrane market has witnessed unmatched growth over the last few decades due to
wide applications in several industries such as healthcare, biotechnology, pharmaceutical, and
others. Currently, medical membranes are commonly used in the healthcare industry to produce
and maintain high quality products. They offer advantages such as high selectivity and
permeability. Hemodialysis is one of the most vital use of semi-permeable membrane in the
artificial treatment of blood.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1800
Medical Membrane Market Dynamics:
Increasing prevalence of naïve infectious chronic diseases such as chronic kidney disease around
the globe is the major factor propelling demand for medical membrane. For instance, according
to the National Kidney Foundation 2018, data around 10% of the worldwide population was
affected by chronic kidney disease. Moreover, increasing government initiatives in research and
development, advancement in healthcare industry, biotechnology, and increasing adoption of
medical membranes in several industries are key factors driving growth of the medical
membrane market. For instance, according to a 2016, United States Government Accountability
Office report, National Institute of Health funding for biomedical research on kidney disease
was US$ 564 million in 2015.